首页> 外文OA文献 >Comparing Phylogeny and the Predicted Pathogenicity of Protein Variations Reveals Equal Purifying Selection across the Global Human mtDNA Diversity
【2h】

Comparing Phylogeny and the Predicted Pathogenicity of Protein Variations Reveals Equal Purifying Selection across the Global Human mtDNA Diversity

机译:系统发育和蛋白质变异的预测致病性的比较揭示了全球人类mtDNA多样性的平等纯化选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We used detailed phylogenetic trees for human mtDNA, combined with pathogenicity predictions for each amino acid change, to evaluate selection on mtDNA-encoded protein variants. Protein variants with high pathogenicity scores were significantly rarer in the older branches of the tree. Variants that have formed and survived multiple times in the human phylogenetics tree had significantly lower pathogenicity scores than those that only appear once in the tree. We compared the distribution of pathogenicity scores observed on the human phylogenetic tree to the distribution of all possible protein variations to define a measure of the effect of selection on these protein variations. The measured effect of selection increased exponentially with increasing pathogenicity score. We found no measurable difference in this measure of purifying selection in mtDNA across the global population, represented by the macrohaplogroups L, M, and N. We provide a list of all possible single amino acid variations for the human mtDNA-encoded proteins with their predicted pathogenicity scores and our measured selection effect as a tool for assessing novel protein variations that are often reported in patients with mitochondrial disease of unknown origin or for assessing somatic mutations acquired through aging or detected in tumors.
机译:我们将详细的系统进化树用于人类mtDNA,并结合每个氨基酸变化的致病性预测,以评估对mtDNA编码的蛋白质变体的选择。具有较高致病性评分的蛋白质变体在树的较老树枝中极为罕见。与仅在树中出现一次的变种相比,在人类系统树中形成并存活多次的变种的致病性得分要低得多。我们将在人类系统树上观察到的致病性得分的分布与所有可能的蛋白质变异的分布进行比较,以定义选择对这些蛋白质变异的影响的度量。选择的测量效果随着致病性评分的增加而呈指数增加。我们发现在全球人群中,以大单体组L,M和N代表的纯化mtDNA的选择纯化方法没有可测量的差异。我们提供了人类mtDNA编码蛋白的所有可能的单个氨基酸变异的列表,以及它们的预测值。致病性评分和我们测得的选择效果,可作为评估未知来源的线粒体疾病患者中经常报道的新型蛋白质变异或评估因衰老而获得或在肿瘤中检测到的体细胞突变的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号